CIK 0001636651 · Non-accelerated filer<br>Smaller reporting company
Ovid Therapeutics Inc.
Sign in to watch- Ticker
- OVID
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465270895
- Phone
- 212-776-4381
- Business address
- 441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY, 10001
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 61 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-12 | Friedman Bart Director | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2024-12-12 | Duncan Barbara Gayle Director | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2024-12-12 | Bernstein Karen Director | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2024-09-09 | ALEXANDER MARGARET A. President and COO | Grant or award · Employee Stock Option (right to buy) | +140,000 | 140,000 | ||
| 2024-07-30 | Rona Jeffrey A CBFO | Grant or award · Employee Stock Option (right to buy) | +315,000 | 315,000 | ||
| 2024-03-18 | LEVIN JEREMY M CEO | Purchase | +18,248 | $2.76 | $50K | 3,616,715 |
| 2024-02-22 | Tardio Jason Chief Operating Officer | Grant or award | +28,125 | 28,125 | ||
| 2024-02-22 | Tardio Jason Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +168,750 | 168,750 | ||
| 2024-02-22 | Rona Jeffrey A CBFO | Grant or award | +28,125 | 28,125 | ||
| 2024-02-22 | Rona Jeffrey A CBFO | Grant or award · Stock Option (Right to Buy) | +168,750 | 0 | ||
| 2024-02-22 | Poole Robert Michael Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-02-22 | Perone Thomas Michael General Counsel, Secretary | Grant or award | +28,125 | 28,125 | ||
| 2024-02-22 | Perone Thomas Michael General Counsel, Secretary | Grant or award · Stock Option (Right to Buy) | +168,750 | 168,750 | ||
| 2024-02-22 | LEVIN JEREMY M CEO | Grant or award · Stock Option (Right to Buy) | +700,000 | 700,000 | ||
| 2024-02-22 | Friedman Bart Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-02-22 | Fitzgerald Kevin Joseph Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-02-22 | Duncan Barbara Gayle Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-02-22 | Bernstein Karen Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-12-04 | LEVIN JEREMY M CEO | Gift | −573,275 | 4,171,742 | ||
| 2023-12-04 | LEVIN JEREMY M CEO | Gift | −573,275 | 3,598,467 |
Page 3 of 7 · 123 trades